Judge reviewing CVS-Aetna $69B merger unlikely to unravel deal

CVS Health is still embroiled in a dispute over its $69 billion merger with Aetna, which was approved by the Department of Justice last year and closed in late 2018. However, U.S. District Judge Richard Leon isn’t so sure the deal hasn’t crossed any antitrust laws and is reviewing the case in court.

CVS Health has recently asked Leon not to allow industry groups to testify in an upcoming hearing that has yet to be set. The hearing is an unusual step in the process to vet the deal by Leon, according to Barron’s.

CVS isn’t likely to see a turnover of the merger by Judge Leon, but the ongoing battle between the court and the Department of Justice brings up several question, according to Barron’s. Under the Tunney Act, Judge Leon has the authority to hold hearing and elicit testimony from experts, but it is unusual for the court to act out of step with the DOJ, Barron’s wrote.

Judge Leon also went head to head with the DOJ in another major merger between AT&T and Time Warner, which the judge approved.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.